AMPHOTERICIN B
Generic: AMPHOTERICIN B
Eugia US LLCManufacturer
INTRAVENOUSRoute
AMPHOTERICIN BActive Substance
2022-11-17Original Approval
AMPHOTERICIN B is FDA application ANDA214010, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
4,098 reports
2
OFF LABEL USE
1,759 reports
3
CONDITION AGGRAVATED
815 reports
4
PYREXIA
795 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
534 reports
6
MULTIPLE ORGAN DYSFUNCTION SYNDROME
530 reports
7
ACUTE KIDNEY INJURY
529 reports
8
SEPSIS
480 reports
9
FEBRILE NEUTROPENIA
470 reports
10
NEUTROPENIA
436 reports